Skip to main content
Top
Published in: European Radiology 10/2020

Open Access 01-10-2020 | Crohn's Disease | Gastrointestinal

Crohn’s disease: prevalence, MR features, and clinical significance of enteric and colonic sinus tracts

Authors: Martina Scharitzer, Bernd Koizar, Harald Vogelsang, Michael Bergmann, Christian Primas, Michael Weber, Wolfgang Schima, Thomas Mang

Published in: European Radiology | Issue 10/2020

Login to get access

Abstract

Objectives

Enteric and colonic sinus tracts are inflammatory complications that precede intestinal fistulas in patients with Crohn’s disease (CD). The aim of this study was to retrospectively determine the prevalence, morphologic features, and outcome of sinus tracts using MR imaging.

Methods

A consecutive cohort of 642 patients with known CD, referred for MR enterography or MR enteroclysis (study period 01/2014–09/2019), was evaluated retrospectively for the presence of sinus tracts, their locations, presence and length of coexisting strictures, bowel wall thickness, CDMI score, upstream dilation, and bowel distension. Clinical outcome was assessed using medical records. For metric data, means and standard deviation, as well as one-way ANOVA and Pearson’s correlation coefficient, were calculated.

Results

In 36/642 patients with CD undergoing MRE, 49 sinus tracts (forty in small intestine, nine in left-sided colon) were detected with a prevalence of 6.9% in patients with MR-visible signs of CD (n = 519, overall prevalence of 5.6%). Mean segmental bowel wall thickness was 8.9 mm, and mean CDMI score was 9.3. All sinus tracts were located within a stenotic segment, showing mesenteric orientation within the small bowel and upstream dilation in 13 patients. Of 36 patients, 19 underwent immediate surgery and seven developed clinical progression within the segment containing the sinus tract.

Conclusions

Sinus tracts occur in 6.9% of patients with visible signs of CD. They are located within stenotic, severely thickened bowel segments with high MR inflammation scores. Their detection is clinically important, because they indicate a more aggressive phenotype and, if left untreated, may show severe progression.

Key Points

• Sinus tracts occur in 6.9% of patients with MR-visible signs of Crohn’s disease.
• Sinus tracts are a radiological indicator of early penetrating Crohn’s disease, with a high risk of progression, and require dedicated treatment.
• Sinus tracts can be recognized by characteristic findings and typically occur in stenotic, severely thickened bowel segments with high MR inflammation scores.
Literature
1.
go back to reference Tolan DJ, Greenhalgh R, Zealley IA, Halligan S, Taylor SA (2010) MR enterographic manifestations of small bowel Crohn disease. Radiographics 30:367–384CrossRef Tolan DJ, Greenhalgh R, Zealley IA, Halligan S, Taylor SA (2010) MR enterographic manifestations of small bowel Crohn disease. Radiographics 30:367–384CrossRef
2.
go back to reference Kaushal P, Somwaru AS, Charabaty A, Levy AD (2017) MR enterography of inflammatory bowel disease with endoscopic correlation. Radiographics 37:116–131CrossRef Kaushal P, Somwaru AS, Charabaty A, Levy AD (2017) MR enterography of inflammatory bowel disease with endoscopic correlation. Radiographics 37:116–131CrossRef
3.
go back to reference Bruining DH, Zimmermann EM, Loftus EV Jr et al (2018) Consensus recommendations for evaluation, interpretation, and utilization of computed tomography and magnetic resonance enterography in patients with small bowel Crohn’s disease. Radiology 286:776–799CrossRef Bruining DH, Zimmermann EM, Loftus EV Jr et al (2018) Consensus recommendations for evaluation, interpretation, and utilization of computed tomography and magnetic resonance enterography in patients with small bowel Crohn’s disease. Radiology 286:776–799CrossRef
4.
go back to reference Oberhuber G, Stangl PC, Vogelsang H, Schober E, Herbst F, Gasche C (2000) Significant association of strictures and internal fistula formation in Crohn’s disease. Virchows Arch 437:293–297CrossRef Oberhuber G, Stangl PC, Vogelsang H, Schober E, Herbst F, Gasche C (2000) Significant association of strictures and internal fistula formation in Crohn’s disease. Virchows Arch 437:293–297CrossRef
5.
go back to reference Bataille F, Rohrmeier C, Bates R et al (2008) Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn’s disease. Inflamm Bowel Dis 14:1514–1527CrossRef Bataille F, Rohrmeier C, Bates R et al (2008) Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn’s disease. Inflamm Bowel Dis 14:1514–1527CrossRef
6.
go back to reference Stange EF, Travis SP, Vermeire S et al (2006) European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut 55(Suppl 1):i1–i15CrossRef Stange EF, Travis SP, Vermeire S et al (2006) European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut 55(Suppl 1):i1–i15CrossRef
7.
go back to reference Maaser C, Sturm A, Vavricka SR et al (2019) ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 13:144–164CrossRef Maaser C, Sturm A, Vavricka SR et al (2019) ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 13:144–164CrossRef
8.
go back to reference Panes J, Bouzas R, Chaparro M et al (2011) Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther 34:125–145CrossRef Panes J, Bouzas R, Chaparro M et al (2011) Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther 34:125–145CrossRef
9.
go back to reference Schecter WP, Hirshberg A, Chang DS et al (2009) Enteric fistulas: principles of management. J Am Coll Surg 209:484–491CrossRef Schecter WP, Hirshberg A, Chang DS et al (2009) Enteric fistulas: principles of management. J Am Coll Surg 209:484–491CrossRef
11.
go back to reference Taylor SA, Avni F, Cronin CG et al (2017) The first joint ESGAR/ ESPR consensus statement on the technical performance of cross-sectional small bowel and colonic imaging. Eur Radiol 27:2570–2582CrossRef Taylor SA, Avni F, Cronin CG et al (2017) The first joint ESGAR/ ESPR consensus statement on the technical performance of cross-sectional small bowel and colonic imaging. Eur Radiol 27:2570–2582CrossRef
12.
go back to reference Tielbeek JA, Makanyanga JC, Bipat S et al (2013) Grading Crohn disease activity with MRI: interobserver variability of MRI features, MRI scoring of severity, and correlation with Crohn disease endoscopic index of severity. AJR Am J Roentgenol 201:1220–1228CrossRef Tielbeek JA, Makanyanga JC, Bipat S et al (2013) Grading Crohn disease activity with MRI: interobserver variability of MRI features, MRI scoring of severity, and correlation with Crohn disease endoscopic index of severity. AJR Am J Roentgenol 201:1220–1228CrossRef
14.
go back to reference Jaffe T, Thompson WM (2015) Large-bowel obstruction in the adult: classic radiographic and CT findings, etiology, and mimics. Radiology 275:651–663CrossRef Jaffe T, Thompson WM (2015) Large-bowel obstruction in the adult: classic radiographic and CT findings, etiology, and mimics. Radiology 275:651–663CrossRef
15.
go back to reference Bekendam MIJ, Puylaert CAJ, Phoa S, Nio CY, Stoker J (2017) Shortened oral contrast preparation for improved small bowel distension at MR enterography. Abdom Radiol (NY) 42:2225–2232CrossRef Bekendam MIJ, Puylaert CAJ, Phoa S, Nio CY, Stoker J (2017) Shortened oral contrast preparation for improved small bowel distension at MR enterography. Abdom Radiol (NY) 42:2225–2232CrossRef
16.
go back to reference Hirten RP, Shah S, Sachar DB, Colombel JF (2018) The management of intestinal penetrating Crohn’s disease. Inflamm Bowel Dis 24:752–765CrossRef Hirten RP, Shah S, Sachar DB, Colombel JF (2018) The management of intestinal penetrating Crohn’s disease. Inflamm Bowel Dis 24:752–765CrossRef
17.
go back to reference Schwartz DA, Loftus EV Jr, Tremaine WJ et al (2002) The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology 122:875–880CrossRef Schwartz DA, Loftus EV Jr, Tremaine WJ et al (2002) The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology 122:875–880CrossRef
18.
go back to reference Kugathasan S, Denson LA, Walters TD et al (2017) Prediction of complicated disease course for children newly diagnosed with Crohn’s disease: a multicentre inception cohort study. Lancet 389:1710–1718CrossRef Kugathasan S, Denson LA, Walters TD et al (2017) Prediction of complicated disease course for children newly diagnosed with Crohn’s disease: a multicentre inception cohort study. Lancet 389:1710–1718CrossRef
19.
go back to reference Bruining DH, Siddiki HA, Fletcher JG, Tremaine WJ, Sandborn WJ, Loftus EV Jr (2008) Prevalence of penetrating disease and extraintestinal manifestations of Crohn’s disease detected with CT enterography. Inflamm Bowel Dis 14:1701–1706CrossRef Bruining DH, Siddiki HA, Fletcher JG, Tremaine WJ, Sandborn WJ, Loftus EV Jr (2008) Prevalence of penetrating disease and extraintestinal manifestations of Crohn’s disease detected with CT enterography. Inflamm Bowel Dis 14:1701–1706CrossRef
20.
go back to reference Molodecky NA, Soon IS, Rabi DM et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142:46–54 e42 quiz e30CrossRef Molodecky NA, Soon IS, Rabi DM et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142:46–54 e42 quiz e30CrossRef
21.
go back to reference Frolkis AD, Dykeman J, Negron ME et al (2013) Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 145:996–1006CrossRef Frolkis AD, Dykeman J, Negron ME et al (2013) Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 145:996–1006CrossRef
22.
go back to reference Hovde O, Moum BA (2012) Epidemiology and clinical course of Crohn’s disease: results from observational studies. World J Gastroenterol 18:1723–1731CrossRef Hovde O, Moum BA (2012) Epidemiology and clinical course of Crohn’s disease: results from observational studies. World J Gastroenterol 18:1723–1731CrossRef
23.
go back to reference Charpentier C, Salleron J, Savoye G et al (2014) Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut 63:423–432CrossRef Charpentier C, Salleron J, Savoye G et al (2014) Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut 63:423–432CrossRef
24.
go back to reference Rozendorn N, Amitai MM, Eliakim RA, Kopylov U, Klang E (2018) A review of magnetic resonance enterography-based indices for quantification of Crohn’s disease inflammation. Therap Adv Gastroenterol 11:1756284818765956CrossRef Rozendorn N, Amitai MM, Eliakim RA, Kopylov U, Klang E (2018) A review of magnetic resonance enterography-based indices for quantification of Crohn’s disease inflammation. Therap Adv Gastroenterol 11:1756284818765956CrossRef
25.
go back to reference Steward MJ, Punwani S, Proctor I et al (2012) Non-perforating small bowel Crohn’s disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol 81:2080–2088CrossRef Steward MJ, Punwani S, Proctor I et al (2012) Non-perforating small bowel Crohn’s disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol 81:2080–2088CrossRef
26.
go back to reference Gore R, Levine M (2008) Ulcerative and granulomatous colitis: idiopathic inflammatory bowel disease. In: Gore RM, Levine MS (eds) Textbook of gastrointestinal radiology. Saunders, Philadelphia, pp 1098–1099 Gore R, Levine M (2008) Ulcerative and granulomatous colitis: idiopathic inflammatory bowel disease. In: Gore RM, Levine MS (eds) Textbook of gastrointestinal radiology. Saunders, Philadelphia, pp 1098–1099
27.
go back to reference Kelly JK, Preshaw RM (1989) Origin of fistulas in Crohn’s disease. J Clin Gastroenterol 11:193–196CrossRef Kelly JK, Preshaw RM (1989) Origin of fistulas in Crohn’s disease. J Clin Gastroenterol 11:193–196CrossRef
28.
go back to reference Orscheln ES, Dillman JR, Towbin AJ, Denson LA, Trout AT (2018) Penetrating Crohn disease: does it occur in the absence of stricturing disease? Abdom Radiol (NY) 43:1583–1589CrossRef Orscheln ES, Dillman JR, Towbin AJ, Denson LA, Trout AT (2018) Penetrating Crohn disease: does it occur in the absence of stricturing disease? Abdom Radiol (NY) 43:1583–1589CrossRef
29.
go back to reference Romberg-Camps MJ, Dagnelie PC, Kester AD et al (2009) Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol 104:371–383CrossRef Romberg-Camps MJ, Dagnelie PC, Kester AD et al (2009) Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol 104:371–383CrossRef
30.
go back to reference Irwin J, Ferguson E, Simms LA, Hanigan K, Carbonnel F, Radford-Smith G (2017) A rolling phenotype in Crohn’s disease. PLoS One 12:e0174954CrossRef Irwin J, Ferguson E, Simms LA, Hanigan K, Carbonnel F, Radford-Smith G (2017) A rolling phenotype in Crohn’s disease. PLoS One 12:e0174954CrossRef
31.
go back to reference Cerqueira RM, Lago PM (2013) Clinical factors predictive of Crohn’s disease complications and surgery. Eur J Gastroenterol Hepatol 25:129–134CrossRef Cerqueira RM, Lago PM (2013) Clinical factors predictive of Crohn’s disease complications and surgery. Eur J Gastroenterol Hepatol 25:129–134CrossRef
32.
go back to reference Toh JW, Stewart P, Rickard MJ, Leong R, Wang N, Young CJ (2016) Indications and surgical options for small bowel, large bowel and perianal Crohn’s disease. World J Gastroenterol 22:8892–8904CrossRef Toh JW, Stewart P, Rickard MJ, Leong R, Wang N, Young CJ (2016) Indications and surgical options for small bowel, large bowel and perianal Crohn’s disease. World J Gastroenterol 22:8892–8904CrossRef
33.
go back to reference Michelassi F, Stella M, Balestracci T, Giuliante F, Marogna P, Block GE (1993) Incidence, diagnosis, and treatment of enteric and colorectal fistulae in patients with Crohn’s disease. Ann Surg 218:660–666CrossRef Michelassi F, Stella M, Balestracci T, Giuliante F, Marogna P, Block GE (1993) Incidence, diagnosis, and treatment of enteric and colorectal fistulae in patients with Crohn’s disease. Ann Surg 218:660–666CrossRef
34.
go back to reference Feagins LA, Holubar SD, Kane SV, Spechler SJ (2011) Current strategies in the management of intra-abdominal abscesses in Crohn’s disease. Clin Gastroenterol Hepatol 9:842–850CrossRef Feagins LA, Holubar SD, Kane SV, Spechler SJ (2011) Current strategies in the management of intra-abdominal abscesses in Crohn’s disease. Clin Gastroenterol Hepatol 9:842–850CrossRef
35.
go back to reference Parsi MA, Lashner BA, Achkar JP, Connor JT, Brzezinski A (2004) Type of fistula determines response to infliximab in patients with fistulous Crohn’s disease. Am J Gastroenterol 99:445–449CrossRef Parsi MA, Lashner BA, Achkar JP, Connor JT, Brzezinski A (2004) Type of fistula determines response to infliximab in patients with fistulous Crohn’s disease. Am J Gastroenterol 99:445–449CrossRef
36.
go back to reference Lee MJ, Parker CE, Taylor SR et al (2018) Efficacy of medical therapies for fistulizing Crohn’s disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 16:1879–1892CrossRef Lee MJ, Parker CE, Taylor SR et al (2018) Efficacy of medical therapies for fistulizing Crohn’s disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 16:1879–1892CrossRef
37.
go back to reference Miehsler W, Reinisch W, Kazemi-Shirazi L et al (2004) Infliximab: lack of efficacy on perforating complications in Crohn’s disease. Inflamm Bowel Dis 10:36–40CrossRef Miehsler W, Reinisch W, Kazemi-Shirazi L et al (2004) Infliximab: lack of efficacy on perforating complications in Crohn’s disease. Inflamm Bowel Dis 10:36–40CrossRef
38.
go back to reference Bemelman WA, Warusavitarne J, Sampietro GM et al (2018) ECCO-ESCP consensus on surgery for Crohn’s disease. J Crohns Colitis 12:1–16CrossRef Bemelman WA, Warusavitarne J, Sampietro GM et al (2018) ECCO-ESCP consensus on surgery for Crohn’s disease. J Crohns Colitis 12:1–16CrossRef
39.
go back to reference Solberg IC, Vatn MH, Hoie O et al (2007) Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 5:1430–1438CrossRef Solberg IC, Vatn MH, Hoie O et al (2007) Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 5:1430–1438CrossRef
40.
go back to reference Law CC, Sasidharan S, Rodrigues R et al (2016) Impact of specialized inpatient IBD care on outcomes of IBD hospitalizations: a cohort study. Inflamm Bowel Dis 22:2149–2157CrossRef Law CC, Sasidharan S, Rodrigues R et al (2016) Impact of specialized inpatient IBD care on outcomes of IBD hospitalizations: a cohort study. Inflamm Bowel Dis 22:2149–2157CrossRef
Metadata
Title
Crohn’s disease: prevalence, MR features, and clinical significance of enteric and colonic sinus tracts
Authors
Martina Scharitzer
Bernd Koizar
Harald Vogelsang
Michael Bergmann
Christian Primas
Michael Weber
Wolfgang Schima
Thomas Mang
Publication date
01-10-2020
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 10/2020
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-06935-1

Other articles of this Issue 10/2020

European Radiology 10/2020 Go to the issue